Funding opportunities now open for 2020
January 31, 2020
The Institute is pleased to announce the launch of the following Canadian funding opportunities:
- Rapid Response: Canada 2020 (Alzheimer’s & Related Diseases / Parkinson’s & Related Diseases)
The Rapid Response: Canada program was created to provide seed funding to catalyse novel, high-risk, high-reward translational research. Preliminary data is not required.
Funding available: Up to $300,000 over up to 18 months per project.
- Transformational Research: Canada 2020 (Alzheimer’s & Related Diseases / Parkinson’s & Related Diseases)
The Transformational Research: Canada program funds transformative, novel, high-risk, high-reward translational research projects.
Funding available: Up to $1,500,000 over up to 3 years per project.
- Weston Brain Institute International Outstanding Achievement Award 2020
In 2020, the award will be honouring a Canadian-based researcher for recent contributions in translational research in neurodegenerative diseases of aging. This $40,000 prize will be provided to the awardee through the institution with which the awardee is affiliated with.
- Early Phase Clinical Trials: Canada
The Early Phase Clinical Trials: Canada program was created to provide funding support for clinical trials and clinical trial sub-studies with excellent preliminary data. This program runs on a rolling basis; applicants may submit an LOI at any time.
Funding available: A maximum of $1,500,000 per project over up to 4 years.
Please follow the above links to each program page to access further information and documents such as program details and sample applications.
If you have any questions , please do not hesitate to contact us by email at email@example.com or by phone at +1 (416) 967 7979.